SGLT2 Inhibitors Linked to Reduced Risk for Serious Renal Events
Data from three countries showed drop in serious renal events with sodium-glucose cotransporter 2 inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.